Global Microneedle-based Drug Delivery System Market Growth (Status and Outlook) 2023-2029

Global Microneedle-based Drug Delivery System Market Growth (Status and Outlook) 2023-2029

Microneedle drug delivery systems usually include Hollow Microneedle Technology microneedle and Dissolving Microneedles Technology microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.

In this report, we mainly study the forecast market due to there is no product on the market, most product on the research.

LPI (LP Information)' newest research report, the “Microneedle-based Drug Delivery System Industry Forecast” looks at past sales and reviews total world Microneedle-based Drug Delivery System sales in 2022, providing a comprehensive analysis by region and market sector of projected Microneedle-based Drug Delivery System sales for 2023 through 2029. With Microneedle-based Drug Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microneedle-based Drug Delivery System industry.

This Insight Report provides a comprehensive analysis of the global Microneedle-based Drug Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microneedle-based Drug Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microneedle-based Drug Delivery System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microneedle-based Drug Delivery System and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microneedle-based Drug Delivery System.

The global Microneedle-based Drug Delivery System market size is projected to grow from US$ 3 million in 2022 to US$ 147.3 million in 2029; it is expected to grow at a CAGR of 77.8% from 2023 to 2029.

Microneedles are a rapidly growing technology developed to solve issues surrounding intradermal drug administration. While many microneedle platforms have been developed over nearly 2 decades, the issues and concerns remain largely the same.

The classification of Microneedle Drug Delivery Systems includes Hollow Microneedle Technology, Solid Microneedle Technology and Dissolving Microneedles Technology, and the proportion of Hollow Microneedle Technology occupies the most proportions.

Microneedle Drug Delivery Systems is widely used in Drug Delivery, Vaccine Delivery and other field. The most proportion of Microneedle Drug Delivery Systems is used for vaccine delivery.

3M, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report presents a comprehensive overview, market shares, and growth opportunities of Microneedle-based Drug Delivery System market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Hollow Microneedle Technology
Solid Microneedle Technology
Dissolving Microneedles Technology

Segmentation by application
Drug Delivery
Vaccine Delivery

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
KINDEVA
Zosano Pharma
Becton-Dickinson(BD)Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect, Inc
Vaxxas
Lohmann Therapie-Systeme AG

Please note: The report will take approximately 2 business days to prepare and deliver.